Comparison of Treatment Retention Between Risperidone Long-Acting Injection and First-Generation Long-Acting Injections in Patients With Schizophrenia for 5 Years

被引：3
|
作者：
Suzuki, Hidenobu [1 ]
Hibino, Hiroyuki [2 ]
Inoue, Yuichi [3 ]
Takaya, Atsuhiko [2 ]
机构：
[1] Suzuki Clin, Dept Psychiat, Tokyo, Japan
[2] Fukui Kinen Hosp, Dept Psychiat, Yokohama, Kanagawa, Japan
[3] Shakomae Kokorono Clin, Dept Psychiat, Tokyo, Japan
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 36卷 / 04期
关键词：
D O I：
10.1097/JCP.0000000000000533
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：405 / 406
页数：3
相关论文
共 50 条
  • [31] Pharmacokinetics of the Long-Acting, First-Generation Antipsychotic Fluphenazine
    Purvis, Tara L.
    Hieber, Robin N.
    Dellenbaugh, Timothy
    Sommi, Roger W.
    PHARMACOTHERAPY, 2011, 31 (04): : 438 - 438
  • [32] Long-acting risperidone injection improves and maintains quality of life in patients with schizophrenia
    Mehnert, A
    Eerdekens, M
    Fleischhacker, WW
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S305 - S305
  • [33] Prescribing practice of risperidone long-acting injection
    Agell, I.
    Gupta, N.
    Riley, C. A.
    EUROPEAN PSYCHIATRY, 2008, 23 : S154 - S154
  • [34] Injection site pain with long-acting risperidone
    Pinninti, NR
    Mago, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (05) : 656 - 657
  • [35] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Mohamed, Somaia
    Rosenheck, Robert
    Harpaz-Rotem, Ilan
    Leslie, Douglas
    Sernyak, Michael J.
    PSYCHIATRIC QUARTERLY, 2009, 80 (04) : 241 - 249
  • [36] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Somaia Mohamed
    Robert Rosenheck
    Ilan Harpaz-Rotem
    Douglas Leslie
    Michael J. Sernyak
    Psychiatric Quarterly, 2009, 80 : 241 - 249
  • [37] Risperidone long-acting injection provoked urinary retention: a case report
    Lee, Wei-Chia
    Chuang, Yao-Chi
    Chiang, Po-Hui
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A249 - A249
  • [38] Comparison of prolactin level in schizophrenia patients treated with risperidone oral or long-acting injections - preliminary report
    Skowronska, Anna
    Strzelecki, Dominik
    Wysokinski, Adam
    ARCHIVES OF CLINICAL PSYCHIATRY, 2021, 48 (01) : 20 - 23
  • [39] A comparison of the effectiveness of risperidone, haloperidol and flupentixol long-acting injections in patients with schizophrenia-A nationwide study
    Yu, Hsaing-Yuan
    Hsiao, Chih Yin
    Chen, Kao Chin
    Lee, Lan-Ting
    Chang, Wei Hung
    Chi, Mei Hung
    Lee, I. Hui
    Chen, Po See
    Yang, Yen Kuang
    SCHIZOPHRENIA RESEARCH, 2015, 169 (1-3) : 400 - 405
  • [40] Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting
    Kim, Borah
    Lee, Sang-Hyuk
    Choi, Tae Kyou
    Suh, ShinYoung
    Kim, Yong Woo
    Lee, EunHee
    Yook, Ki Hwan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05): : 1231 - 1235
12345